US Bancorp DE Trims Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

US Bancorp DE decreased its holdings in Azenta, Inc. (NASDAQ:AZTAGet Rating) by 19.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,483 shares of the company’s stock after selling 15,280 shares during the period. US Bancorp DE owned 0.08% of Azenta worth $2,678,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Amalgamated Bank purchased a new position in Azenta during the first quarter valued at approximately $4,552,000. Moody National Bank Trust Division purchased a new position in Azenta during the second quarter valued at approximately $753,000. AdvisorNet Financial Inc purchased a new position in Azenta in the 2nd quarter worth approximately $50,000. Green Alpha Advisors LLC purchased a new position in Azenta in the 2nd quarter worth approximately $864,000. Finally, State of Alaska Department of Revenue purchased a new position in Azenta in the 2nd quarter worth approximately $775,000. Hedge funds and other institutional investors own 96.42% of the company’s stock.

Azenta Stock Performance

Shares of AZTA opened at $59.82 on Friday. The firm has a market cap of $4.13 billion, a price-to-earnings ratio of 2.11 and a beta of 1.61. Azenta, Inc. has a fifty-two week low of $37.61 and a fifty-two week high of $93.39. The firm has a 50 day moving average price of $57.45 and a 200-day moving average price of $56.16.

Azenta (NASDAQ:AZTAGet Rating) last announced its quarterly earnings data on Monday, November 14th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.10. The firm had revenue of $137.57 million during the quarter, compared to analyst estimates of $132.01 million. Azenta had a net margin of 383.23% and a return on equity of 1.31%. As a group, equities research analysts predict that Azenta, Inc. will post 0.33 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on AZTA. TheStreet raised shares of Azenta from a “d+” rating to a “c-” rating in a research note on Tuesday, December 13th. Stephens boosted their price target on shares of Azenta from $60.00 to $65.00 in a research note on Thursday, November 17th. Needham & Company LLC boosted their price target on shares of Azenta from $74.00 to $78.00 and gave the stock a “buy” rating in a research note on Tuesday, November 15th. Finally, KeyCorp cut their price target on shares of Azenta from $90.00 to $70.00 and set an “overweight” rating for the company in a research note on Monday, October 24th. Four research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $72.60.

About Azenta

(Get Rating)

Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.